News & Events

BD Biosciences, a segment of BD, won the 2008 Life Science Industry Award at a recent ceremony in Boston, MA for offering the best flow cytometry instruments for cell biology research.

This year’s award marks the fourth consecutive year BD Biosciences has won the top award in the “Cell Biology Instruments-Flow Cytometer-Based” category.

“We are honored to be selected for this important Life Science Industry Award again this year,” said Bill Rhodes, President, Cell Analysis, BD Biosciences. “This award reflects the high standards of quality, service and innovation that we are committed to providing our customers as they strive to understand disease and improve care.”

BD Biosciences is a pioneer and leader in the field of flow cytometry for cellular analysis. BD manufactured the first BD FACS™ (fluorescence-activated cell sorting) system in 1973. Today, BD Biosciences offers broad portfolios of research and clinical flow cytometry platforms and reagents designed for cellular characterization and sorting.

Every year, the prestigious Life Science Industry Awards distinguish life science suppliers with the best solution in 14 separate product categories, as well as suppliers that are “best-in-class” in six customer communications and support categories. The Awards are selected by the industry’s customers—scientists in biotechnology and pharmaceutical companies, as well as government and academia. Over 4,500 scientists from around the world were independently surveyed by BioInformatics, LLC, a leading market research firm. More than 500 individual companies were nominated and only 45 achieved the status of Finalist.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

###